Global Novel Drug Delivery Systems Market Insights and Forecast to 2028

TABLE OF CONTENTS

1 Report Business Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Novel Drug Delivery Systems Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 Liposomes
  • 1.2.3 PEGylated Proteins & Polypeptides
  • 1.2.4 Polymer Nanoparticle
  • 1.2.5 Protein-drug Conjugates
  • 1.2.6 Others
• 1.3 Market by Application
  • 1.3.1 Global Novel Drug Delivery Systems Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Hospitals & Clinic
  • 1.3.3 Cancer Treatment Centers
  • 1.3.4 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Novel Drug Delivery Systems Market Perspective (2017-2028)
• 2.2 Novel Drug Delivery Systems Growth Trends by Region
  • 2.2.1 Novel Drug Delivery Systems Market Size by Region: 2017 VS 2021 VS 2028
  • 2.2.2 Novel Drug Delivery Systems Historic Market Size by Region (2017-2022)
  • 2.2.3 Novel Drug Delivery Systems Forecasted Market Size by Region (2023-2028)
• 2.3 Novel Drug Delivery Systems Market Dynamics
  • 2.3.1 Novel Drug Delivery Systems Industry Trends
  • 2.3.2 Novel Drug Delivery Systems Market Drivers
  • 2.3.3 Novel Drug Delivery Systems Market Challenges
  • 2.3.4 Novel Drug Delivery Systems Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Novel Drug Delivery Systems Players by Revenue
  • 3.1.1 Global Top Novel Drug Delivery Systems Players by Revenue (2017-2022)
  • 3.1.2 Global Novel Drug Delivery Systems Revenue Market Share by Players (2017-2022)
• 3.2 Global Novel Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Players Covered: Ranking by Novel Drug Delivery Systems Revenue
• 3.4 Global Novel Drug Delivery Systems Market Concentration Ratio
  • 3.4.1 Global Novel Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Novel Drug Delivery Systems Revenue in 2021
• 3.5 Novel Drug Delivery Systems Key Players Head office and Area Served
• 3.6 Key Players Novel Drug Delivery Systems Product Solution and Service
• 3.7 Date of Enter into Novel Drug Delivery Systems Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Novel Drug Delivery Systems Breakdown Data by Type

• 4.1 Global Novel Drug Delivery Systems Historic Market Size by Type (2017-2022)
• 4.2 Global Novel Drug Delivery Systems Forecasted Market Size by Type (2023-2028)

5 Novel Drug Delivery Systems Breakdown Data by Application

• 5.1 Global Novel Drug Delivery Systems Historic Market Size by Application (2017-2022)
• 5.2 Global Novel Drug Delivery Systems Forecasted Market Size by Application (2023-2028)

6 North America

• 6.1 North America Novel Drug Delivery Systems Market Size (2017-2028)
• 6.2 North America Novel Drug Delivery Systems Market Size by Type
  • 6.2.1 North America Novel Drug Delivery Systems Market Size by Type (2017-2022)
  • 6.2.2 North America Novel Drug Delivery Systems Market Size by Type (2023-2028)
  • 6.2.3 North America Novel Drug Delivery Systems Market Share by Type (2017-2028)
• 6.3 North America Novel Drug Delivery Systems Market Size by Application
  • 6.3.1 North America Novel Drug Delivery Systems Market Size by Application (2017-2022)
  • 6.3.2 North America Novel Drug Delivery Systems Market Size by Application (2023-2028)
  • 6.3.3 North America Novel Drug Delivery Systems Market Share by Application (2017-2028)
• 6.4 North America Novel Drug Delivery Systems Market Size by Country
  • 6.4.1 North America Novel Drug Delivery Systems Market Size by Country (2017-2022)
  • 6.4.2 North America Novel Drug Delivery Systems Market Size by Country (2023-2028)
  • 6.4.3 U.S.
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Novel Drug Delivery Systems Market Size (2017-2028)
• 7.2 Europe Novel Drug Delivery Systems Market Size by Type
  • 7.2.1 Europe Novel Drug Delivery Systems Market Size by Type (2017-2022)
  • 7.2.2 Europe Novel Drug Delivery Systems Market Size by Type (2023-2028)
  • 7.2.3 Europe Novel Drug Delivery Systems Market Share by Type (2017-2028)
• 7.3 Europe Novel Drug Delivery Systems Market Size by Application
  • 7.3.1 Europe Novel Drug Delivery Systems Market Size by Application (2017-2022)
  • 7.3.2 Europe Novel Drug Delivery Systems Market Size by Application (2023-2028)
  • 7.3.3 Europe Novel Drug Delivery Systems Market Share by Application (2017-2028)
• 7.4 Europe Novel Drug Delivery Systems Market Size by Country
  • 7.4.1 Europe Novel Drug Delivery Systems Market Size by Country (2017-2022)
  • 7.4.2 Europe Novel Drug Delivery Systems Market Size by Country (2023-2028)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic Countries

8 Asia-Pacific

• 8.1 Asia-Pacific Novel Drug Delivery Systems Market Size (2017-2028)
• 8.2 Asia-Pacific Novel Drug Delivery Systems Market Size by Type
  • 8.2.1 Asia-Pacific Novel Drug Delivery Systems Market Size by Type (2017-2022)
  • 8.2.2 Asia-Pacific Novel Drug Delivery Systems Market Size by Type (2023-2028)
  • 8.2.3 Asia-Pacific Novel Drug Delivery Systems Market Share by Type (2017-2028)
• 8.3 Asia-Pacific Novel Drug Delivery Systems Market Size by Application
  • 8.3.1 Asia-Pacific Novel Drug Delivery Systems Market Size by Application (2017-2022)
  • 8.3.2 Asia-Pacific Novel Drug Delivery Systems Market Size by Application (2023-2028)
  • 8.3.3 Asia-Pacific Novel Drug Delivery Systems Market Share by Application (2017-2028)
• 8.4 Asia-Pacific Novel Drug Delivery Systems Market Size by Region
  • 8.4.1 Asia-Pacific Novel Drug Delivery Systems Market Size by Region (2017-2022)
  • 8.4.2 Asia-Pacific Novel Drug Delivery Systems Market Size by Region (2023-2028)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Novel Drug Delivery Systems Market Size (2017-2028)
• 9.2 Latin America Novel Drug Delivery Systems Market Size by Type
  • 9.2.1 Latin America Novel Drug Delivery Systems Market Size by Type (2017-2022)
  • 9.2.2 Latin America Novel Drug Delivery Systems Market Size by Type (2023-2028)
  • 9.2.3 Latin America Novel Drug Delivery Systems Market Share by Type (2017-2028)
• 9.3 Latin America Novel Drug Delivery Systems Market Size by Application
  • 9.3.1 Latin America Novel Drug Delivery Systems Market Size by Application (2017-2022)
  • 9.3.2 Latin America Novel Drug Delivery Systems Market Size by Application (2023-2028)
  • 9.3.3 Latin America Novel Drug Delivery Systems Market Share by Application (2017-2028)
• 9.4 Latin America Novel Drug Delivery Systems Market Size by Country
  • 9.4.1 Latin America Novel Drug Delivery Systems Market Size by Country (2017-2022)
  • 9.4.2 Latin America Novel Drug Delivery Systems Market Size by Country (2023-2028)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Novel Drug Delivery Systems Market Size (2017-2028)
• 10.2 Middle East & Africa Novel Drug Delivery Systems Market Size by Type
  • 10.2.1 Middle East & Africa Novel Drug Delivery Systems Market Size by Type (2017-2022)
  • 10.2.2 Middle East & Africa Novel Drug Delivery Systems Market Size by Type (2023-2028)
  • 10.2.3 Middle East & Africa Novel Drug Delivery Systems Market Share by Type (2017-2028)
• 10.3 Middle East & Africa Novel Drug Delivery Systems Market Size by Application
  • 10.3.1 Middle East & Africa Novel Drug Delivery Systems Market Size by Application (2017-2022)
  • 10.3.2 Middle East & Africa Novel Drug Delivery Systems Market Size by Application (2023-2028)
  • 10.3.3 Middle East & Africa Novel Drug Delivery Systems Market Share by Application (2017-2028)
• 10.4 Middle East & Africa Novel Drug Delivery Systems Market Size by Country
  • 10.4.1 Middle East & Africa Novel Drug Delivery Systems Market Size by Country (2017-2022)
  • 10.4.2 Middle East & Africa Novel Drug Delivery Systems Market Size by Country (2023-2028)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Amgen
  • 11.1.1 Amgen Company Details
  • 11.1.2 Amgen Business Overview
  • 11.1.3 Amgen Novel Drug Delivery Systems Introduction
  • 11.1.4 Amgen Revenue in Novel Drug Delivery Systems Business (2017-2022)
  • 11.1.5 Amgen Recent Developments
• 11.2 Teva
  • 11.2.1 Teva Company Details
  • 11.2.2 Teva Business Overview
  • 11.2.3 Teva Novel Drug Delivery Systems Introduction
  • 11.2.4 Teva Revenue in Novel Drug Delivery Systems Business (2017-2022)
  • 11.2.5 Teva Recent Developments
• 11.3 Roche
  • 11.3.1 Roche Company Details
  • 11.3.2 Roche Business Overview
  • 11.3.3 Roche Novel Drug Delivery Systems Introduction
  • 11.3.4 Roche Revenue in Novel Drug Delivery Systems Business (2017-2022)
  • 11.3.5 Roche Recent Developments
• 11.4 UCB (Union Chimique Belge)
  • 11.4.1 UCB (Union Chimique Belge) Company Details
  • 11.4.2 UCB (Union Chimique Belge) Business Overview
  • 11.4.3 UCB (Union Chimique Belge) Novel Drug Delivery Systems Introduction
  • 11.4.4 UCB (Union Chimique Belge) Revenue in Novel Drug Delivery Systems Business (2017-2022)
  • 11.4.5 UCB (Union Chimique Belge) Recent Developments
• 11.5 Celgene
  • 11.5.1 Celgene Company Details
  • 11.5.2 Celgene Business Overview
  • 11.5.3 Celgene Novel Drug Delivery Systems Introduction
  • 11.5.4 Celgene Revenue in Novel Drug Delivery Systems Business (2017-2022)
  • 11.5.5 Celgene Recent Developments
• 11.6 Merck
  • 11.6.1 Merck Company Details
  • 11.6.2 Merck Business Overview
  • 11.6.3 Merck Novel Drug Delivery Systems Introduction
  • 11.6.4 Merck Revenue in Novel Drug Delivery Systems Business (2017-2022)
  • 11.6.5 Merck Recent Developments
• 11.7 Gilead Sciences
  • 11.7.1 Gilead Sciences Company Details
  • 11.7.2 Gilead Sciences Business Overview
  • 11.7.3 Gilead Sciences Novel Drug Delivery Systems Introduction
  • 11.7.4 Gilead Sciences Revenue in Novel Drug Delivery Systems Business (2017-2022)
  • 11.7.5 Gilead Sciences Recent Developments
• 11.8 Sanofi
  • 11.8.1 Sanofi Company Details
  • 11.8.2 Sanofi Business Overview
  • 11.8.3 Sanofi Novel Drug Delivery Systems Introduction
  • 11.8.4 Sanofi Revenue in Novel Drug Delivery Systems Business (2017-2022)
  • 11.8.5 Sanofi Recent Developments
• 11.9 Pfizer
  • 11.9.1 Pfizer Company Details
  • 11.9.2 Pfizer Business Overview
  • 11.9.3 Pfizer Novel Drug Delivery Systems Introduction
  • 11.9.4 Pfizer Revenue in Novel Drug Delivery Systems Business (2017-2022)
  • 11.9.5 Pfizer Recent Developments
• 11.10 Takeda
  • 11.10.1 Takeda Company Details
  • 11.10.2 Takeda Business Overview
  • 11.10.3 Takeda Novel Drug Delivery Systems Introduction
  • 11.10.4 Takeda Revenue in Novel Drug Delivery Systems Business (2017-2022)
  • 11.10.5 Takeda Recent Developments
• 11.11 Bausch&Lomb
  • 11.11.1 Bausch&Lomb Company Details
  • 11.11.2 Bausch&Lomb Business Overview
  • 11.11.3 Bausch&Lomb Novel Drug Delivery Systems Introduction
  • 11.11.4 Bausch&Lomb Revenue in Novel Drug Delivery Systems Business (2017-2022)
  • 11.11.5 Bausch&Lomb Recent Developments
• 11.12 Samyang Biopharmaceuticals
  • 11.12.1 Samyang Biopharmaceuticals Company Details
  • 11.12.2 Samyang Biopharmaceuticals Business Overview
  • 11.12.3 Samyang Biopharmaceuticals Novel Drug Delivery Systems Introduction
  • 11.12.4 Samyang Biopharmaceuticals Revenue in Novel Drug Delivery Systems Business (2017-2022)
  • 11.12.5 Samyang Biopharmaceuticals Recent Developments
• 11.13 Johnson & Johnson
  • 11.13.1 Johnson & Johnson Company Details
  • 11.13.2 Johnson & Johnson Business Overview
  • 11.13.3 Johnson & Johnson Novel Drug Delivery Systems Introduction
  • 11.13.4 Johnson & Johnson Revenue in Novel Drug Delivery Systems Business (2017-2022)
  • 11.13.5 Johnson & Johnson Recent Developments
• 11.14 TOLMAR
  • 11.14.1 TOLMAR Company Details
  • 11.14.2 TOLMAR Business Overview
  • 11.14.3 TOLMAR Novel Drug Delivery Systems Introduction
  • 11.14.4 TOLMAR Revenue in Novel Drug Delivery Systems Business (2017-2022)
  • 11.14.5 TOLMAR Recent Developments
• 11.15 Astellas
  • 11.15.1 Astellas Company Details
  • 11.15.2 Astellas Business Overview
  • 11.15.3 Astellas Novel Drug Delivery Systems Introduction
  • 11.15.4 Astellas Revenue in Novel Drug Delivery Systems Business (2017-2022)
  • 11.15.5 Astellas Recent Developments
• 11.16 AMAG Pharmaceuticals
  • 11.16.1 AMAG Pharmaceuticals Company Details
  • 11.16.2 AMAG Pharmaceuticals Business Overview
  • 11.16.3 AMAG Pharmaceuticals Novel Drug Delivery Systems Introduction
  • 11.16.4 AMAG Pharmaceuticals Revenue in Novel Drug Delivery Systems Business (2017-2022)
  • 11.16.5 AMAG Pharmaceuticals Recent Developments
• 11.17 AbbVie
  • 11.17.1 AbbVie Company Details
  • 11.17.2 AbbVie Business Overview
  • 11.17.3 AbbVie Novel Drug Delivery Systems Introduction
  • 11.17.4 AbbVie Revenue in Novel Drug Delivery Systems Business (2017-2022)
  • 11.17.5 AbbVie Recent Developments
• 11.18 Dr Reddy
  • 11.18.1 Dr Reddy Company Details
  • 11.18.2 Dr Reddy Business Overview
  • 11.18.3 Dr Reddy Novel Drug Delivery Systems Introduction
  • 11.18.4 Dr Reddy Revenue in Novel Drug Delivery Systems Business (2017-2022)
  • 11.18.5 Dr Reddy Recent Developments
• 11.19 AstraZeneca
  • 11.19.1 AstraZeneca Company Details
  • 11.19.2 AstraZeneca Business Overview
  • 11.19.3 AstraZeneca Novel Drug Delivery Systems Introduction
  • 11.19.4 AstraZeneca Revenue in Novel Drug Delivery Systems Business (2017-2022)
  • 11.19.5 AstraZeneca Recent Developments
• 11.20 Aspen
  • 11.20.1 Aspen Company Details
  • 11.20.2 Aspen Business Overview
  • 11.20.3 Aspen Novel Drug Delivery Systems Introduction
  • 11.20.4 Aspen Revenue in Novel Drug Delivery Systems Business (2017-2022)
  • 11.20.5 Aspen Recent Developments
• 11.21 Acrotech Biopharma
  • 11.21.1 Acrotech Biopharma Company Details
  • 11.21.2 Acrotech Biopharma Business Overview
  • 11.21.3 Acrotech Biopharma Novel Drug Delivery Systems Introduction
  • 11.21.4 Acrotech Biopharma Revenue in Novel Drug Delivery Systems Business (2017-2022)
  • 11.21.5 Acrotech Biopharma Recent Developments
• 11.22 TWi Pharmaceuticals
  • 11.22.1 TWi Pharmaceuticals Company Details
  • 11.22.2 TWi Pharmaceuticals Business Overview
  • 11.22.3 TWi Pharmaceuticals Novel Drug Delivery Systems Introduction
  • 11.22.4 TWi Pharmaceuticals Revenue in Novel Drug Delivery Systems Business (2017-2022)
  • 11.22.5 TWi Pharmaceuticals Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Author Details
• 13.3 Disclaimer

• Table 1. Global Novel Drug Delivery Systems Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
• Table 2. Key Players of Liposomes
• Table 3. Key Players of PEGylated Proteins & Polypeptides
• Table 4. Key Players of Polymer Nanoparticle
• Table 5. Key Players of Protein-drug Conjugates
• Table 6. Key Players of Others
• Table 7. Global Novel Drug Delivery Systems Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
• Table 8. Global Novel Drug Delivery Systems Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
• Table 9. Global Novel Drug Delivery Systems Market Size by Region (2017-2022) & (US$ Million)
• Table 10. Global Novel Drug Delivery Systems Market Share by Region (2017-2022)
• Table 11. Global Novel Drug Delivery Systems Forecasted Market Size by Region (2023-2028) & (US$ Million)
• Table 12. Global Novel Drug Delivery Systems Market Share by Region (2023-2028)
• Table 13. Novel Drug Delivery Systems Market Trends
• Table 14. Novel Drug Delivery Systems Market Drivers
• Table 15. Novel Drug Delivery Systems Market Challenges
• Table 16. Novel Drug Delivery Systems Market Restraints
• Table 17. Global Novel Drug Delivery Systems Revenue by Players (2017-2022) & (US$ Million)
• Table 18. Global Novel Drug Delivery Systems Revenue Share by Players (2017-2022)
• Table 19. Global Top Novel Drug Delivery Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Drug Delivery Systems as of 2021)
• Table 20. Ranking of Global Top Novel Drug Delivery Systems Companies by Revenue (US$ Million) in 2021
• Table 21. Global 5 Largest Players Market Share by Novel Drug Delivery Systems Revenue (CR5 and HHI) & (2017-2022)
• Table 22. Key Players Headquarters and Area Served
• Table 23. Key Players Novel Drug Delivery Systems Product Solution and Service
• Table 24. Date of Enter into Novel Drug Delivery Systems Market
• Table 25. Mergers & Acquisitions, Expansion Plans
• Table 26. Global Novel Drug Delivery Systems Market Size by Type (2017-2022) & (US$ Million)
• Table 27. Global Novel Drug Delivery Systems Revenue Market Share by Type (2017-2022)
• Table 28. Global Novel Drug Delivery Systems Forecasted Market Size by Type (2023-2028) & (US$ Million)
• Table 29. Global Novel Drug Delivery Systems Revenue Market Share by Type (2023-2028)
• Table 30. Global Novel Drug Delivery Systems Market Size by Application (2017-2022) & (US$ Million)
• Table 31. Global Novel Drug Delivery Systems Revenue Share by Application (2017-2022)
• Table 32. Global Novel Drug Delivery Systems Forecasted Market Size by Application (2023-2028) & (US$ Million)
• Table 33. Global Novel Drug Delivery Systems Revenue Share by Application (2023-2028)
• Table 34. North America Novel Drug Delivery Systems Market Size by Type (2017-2022) & (US$ Million)
• Table 35. North America Novel Drug Delivery Systems Market Size by Type (2023-2028) & (US$ Million)
• Table 36. North America Novel Drug Delivery Systems Market Size by Application (2017-2022) & (US$ Million)
• Table 37. North America Novel Drug Delivery Systems Market Size by Application (2023-2028) & (US$ Million)
• Table 38. North America Novel Drug Delivery Systems Market Size by Country (2017-2022) & (US$ Million)
• Table 39. North America Novel Drug Delivery Systems Market Size by Country (2023-2028) & (US$ Million)
• Table 40. Europe Novel Drug Delivery Systems Market Size by Type (2017-2022) & (US$ Million)
• Table 41. Europe Novel Drug Delivery Systems Market Size by Type (2023-2028) & (US$ Million)
• Table 42. Europe Novel Drug Delivery Systems Market Size by Application (2017-2022) & (US$ Million)
• Table 43. Europe Novel Drug Delivery Systems Market Size by Application (2023-2028) & (US$ Million)
• Table 44. Europe Novel Drug Delivery Systems Market Size by Country (2017-2022) & (US$ Million)
• Table 45. Europe Novel Drug Delivery Systems Market Size by Country (2023-2028) & (US$ Million)
• Table 46. Asia Pacific Novel Drug Delivery Systems Market Size by Type (2017-2022) & (US$ Million)
• Table 47. Asia Pacific Novel Drug Delivery Systems Market Size by Type (2023-2028) & (US$ Million)
• Table 48. Asia Pacific Novel Drug Delivery Systems Market Size by Application (2017-2022) & (US$ Million)
• Table 49. Asia Pacific Novel Drug Delivery Systems Market Size by Application (2023-2028) & (US$ Million)
• Table 50. Asia Pacific Novel Drug Delivery Systems Market Size by Region (2017-2022) & (US$ Million)
• Table 51. Asia Pacific Novel Drug Delivery Systems Market Size by Region (2023-2028) & (US$ Million)
• Table 52. Latin America Novel Drug Delivery Systems Market Size by Type (2017-2022) & (US$ Million)
• Table 53. Latin America Novel Drug Delivery Systems Market Size by Type (2023-2028) & (US$ Million)
• Table 54. Latin America Novel Drug Delivery Systems Market Size by Application (2017-2022) & (US$ Million)
• Table 55. Latin America Novel Drug Delivery Systems Market Size by Application (2023-2028) & (US$ Million)
• Table 56. Latin America Novel Drug Delivery Systems Market Size by Country (2017-2022) & (US$ Million)
• Table 57. Latin America Novel Drug Delivery Systems Market Size by Country (2023-2028) & (US$ Million)
• Table 58. Middle East and Africa Novel Drug Delivery Systems Market Size by Type (2017-2022) & (US$ Million)
• Table 59. Middle East and Africa Novel Drug Delivery Systems Market Size by Type (2023-2028) & (US$ Million)
• Table 60. Middle East and Africa Novel Drug Delivery Systems Market Size by Application (2017-2022) & (US$ Million)
• Table 61. Middle East and Africa Novel Drug Delivery Systems Market Size by Application (2023-2028) & (US$ Million)
• Table 62. Middle East and Africa Novel Drug Delivery Systems Market Size by Country (2017-2022) & (US$ Million)
• Table 63. Middle East and Africa Novel Drug Delivery Systems Market Size by Country (2023-2028) & (US$ Million)
• Table 64. Amgen Company Details
• Table 65. Amgen Business Overview
• Table 66. Amgen Novel Drug Delivery Systems Product
• Table 67. Amgen Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
• Table 68. Amgen Recent Developments
• Table 69. Teva Company Details
• Table 70. Teva Business Overview
• Table 71. Teva Novel Drug Delivery Systems Product
• Table 72. Teva Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
• Table 73. Teva Recent Developments
• Table 74. Roche Company Details
• Table 75. Roche Business Overview
• Table 76. Roche Novel Drug Delivery Systems Product
• Table 77. Roche Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
• Table 78. Roche Recent Developments
• Table 79. UCB (Union Chimique Belge) Company Details
• Table 80. UCB (Union Chimique Belge) Business Overview
• Table 81. UCB (Union Chimique Belge) Novel Drug Delivery Systems Product
• Table 82. UCB (Union Chimique Belge) Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
• Table 83. UCB (Union Chimique Belge) Recent Developments
• Table 84. Celgene Company Details
• Table 85. Celgene Business Overview
• Table 86. Celgene Novel Drug Delivery Systems Product
• Table 87. Celgene Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
• Table 88. Celgene Recent Developments
• Table 89. Merck Company Details
• Table 90. Merck Business Overview
• Table 91. Merck Novel Drug Delivery Systems Product
• Table 92. Merck Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
• Table 93. Merck Recent Developments
• Table 94. Gilead Sciences Company Details
• Table 95. Gilead Sciences Business Overview
• Table 96. Gilead Sciences Novel Drug Delivery Systems Product
• Table 97. Gilead Sciences Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
• Table 98. Gilead Sciences Recent Developments
• Table 99. Sanofi Company Details
• Table 100. Sanofi Business Overview
• Table 101. Sanofi Novel Drug Delivery Systems Product
• Table 102. Sanofi Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
• Table 103. Sanofi Recent Developments
• Table 104. Pfizer Company Details
• Table 105. Pfizer Business Overview
• Table 106. Pfizer Novel Drug Delivery Systems Product
• Table 107. Pfizer Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
• Table 108. Pfizer Recent Developments
• Table 109. Takeda Company Details
• Table 110. Takeda Business Overview
• Table 111. Takeda Novel Drug Delivery Systems Product
• Table 112. Takeda Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
• Table 113. Takeda Recent Developments
• Table 114. Bausch&Lomb Company Details
• Table 115. Bausch&Lomb Business Overview
• Table 116. Bausch&Lomb Novel Drug Delivery Systems Product
• Table 117. Bausch&Lomb Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
• Table 118. Bausch&Lomb Recent Developments
• Table 119. Samyang Biopharmaceuticals Company Details
• Table 120. Samyang Biopharmaceuticals Business Overview
• Table 121. Samyang Biopharmaceuticals Novel Drug Delivery Systems Product
• Table 122. Samyang Biopharmaceuticals Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
• Table 123. Samyang Biopharmaceuticals Recent Developments
• Table 124. Johnson & Johnson Company Details
• Table 125. Johnson & Johnson Business Overview
• Table 126. Johnson & Johnson Novel Drug Delivery Systems Product
• Table 127. Johnson & Johnson Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
• Table 128. Johnson & Johnson Recent Developments
• Table 129. TOLMAR Company Details
• Table 130. TOLMAR Business Overview
• Table 131. TOLMAR Novel Drug Delivery Systems Product
• Table 132. TOLMAR Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
• Table 133. TOLMAR Recent Developments
• Table 134. Astellas Company Details
• Table 135. Astellas Business Overview
• Table 136. Astellas Novel Drug Delivery Systems Product
• Table 137. Astellas Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
• Table 138. Astellas Recent Developments
• Table 139. AMAG Pharmaceuticals Company Details
• Table 140. AMAG Pharmaceuticals Business Overview
• Table 141. AMAG Pharmaceuticals Novel Drug Delivery Systems Product
• Table 142. AMAG Pharmaceuticals Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
• Table 143. AMAG Pharmaceuticals Recent Developments
• Table 144. AbbVie Company Details
• Table 145. AbbVie Business Overview
• Table 146. AbbVie Novel Drug Delivery Systems Product
• Table 147. AbbVie Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
• Table 148. AbbVie Recent Developments
• Table 149. Dr Reddy Company Details
• Table 150. Dr Reddy Business Overview
• Table 151. Dr Reddy Novel Drug Delivery Systems Product
• Table 152. Dr Reddy Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
• Table 153. Dr Reddy Recent Developments
• Table 154. AstraZeneca Company Details
• Table 155. AstraZeneca Business Overview
• Table 156. AstraZeneca Novel Drug Delivery Systems Product
• Table 157. AstraZeneca Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
• Table 158. AstraZeneca Recent Developments
• Table 159. Aspen Company Details
• Table 160. Aspen Business Overview
• Table 161. Aspen Novel Drug Delivery Systems Product
• Table 162. Aspen Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
• Table 163. Aspen Recent Developments
• Table 164. Acrotech Biopharma Company Details
• Table 165. Acrotech Biopharma Business Overview
• Table 166. Acrotech Biopharma Novel Drug Delivery Systems Product
• Table 167. Acrotech Biopharma Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
• Table 168. Acrotech Biopharma Recent Developments
• Table 169. TWi Pharmaceuticals Company Details
• Table 170. TWi Pharmaceuticals Business Overview
• Table 171. TWi Pharmaceuticals Novel Drug Delivery Systems Product
• Table 172. TWi Pharmaceuticals Revenue in Novel Drug Delivery Systems Business (2017-2022) & (US$ Million)
• Table 173. TWi Pharmaceuticals Recent Developments
• Table 174. Research Programs/Design for This Report
• Table 175. Key Data Information from Secondary Sources
• Table 176. Key Data Information from Primary Sources

List of Figures

• Figure 1. Global Novel Drug Delivery Systems Market Share by Type: 2021 VS 2028
• Figure 2. Liposomes Features
• Figure 3. PEGylated Proteins & Polypeptides Features
• Figure 4. Polymer Nanoparticle Features
• Figure 5. Protein-drug Conjugates Features
• Figure 6. Others Features
• Figure 7. Global Novel Drug Delivery Systems Market Share by Application: 2021 VS 2028
• Figure 8. Hospitals & Clinic Case Studies
• Figure 9. Cancer Treatment Centers Case Studies
• Figure 10. Others Case Studies
• Figure 11. Novel Drug Delivery Systems Report Years Considered
• Figure 12. Global Novel Drug Delivery Systems Market Size (US$ Million), Year-over-Year: 2017-2028
• Figure 13. Global Novel Drug Delivery Systems Market Size, (US$ Million), 2017 VS 2021 VS 2028
• Figure 14. Global Novel Drug Delivery Systems Market Share by Region: 2021 VS 2028
• Figure 15. Global Novel Drug Delivery Systems Market Share by Players in 2021
• Figure 16. Global Top Novel Drug Delivery Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Drug Delivery Systems as of 2021)
• Figure 17. The Top 10 and 5 Players Market Share by Novel Drug Delivery Systems Revenue in 2021
• Figure 18. North America Novel Drug Delivery Systems Market Size YoY (2017-2028) & (US$ Million)
• Figure 19. North America Novel Drug Delivery Systems Market Size Market Share by Type (2017-2028)
• Figure 20. North America Novel Drug Delivery Systems Market Size Market Share by Application (2017-2028)
• Figure 21. North America Novel Drug Delivery Systems Market Size Share by Country (2017-2028)
• Figure 22. United States Novel Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 23. Canada Novel Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 24. Europe Novel Drug Delivery Systems Market Size YoY (2017-2028) & (US$ Million)
• Figure 25. Europe Novel Drug Delivery Systems Market Size Market Share by Type (2017-2028)
• Figure 26. Europe Novel Drug Delivery Systems Market Size Market Share by Application (2017-2028)
• Figure 27. Europe Novel Drug Delivery Systems Market Size Share by Country (2017-2028)
• Figure 28. Germany Novel Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 29. France Novel Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 30. U.K. Novel Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 31. Italy Novel Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 32. Russia Novel Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 33. Nordic Countries Novel Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 34. Asia-Pacific Novel Drug Delivery Systems Market Size YoY (2017-2028) & (US$ Million)
• Figure 35. Asia Pacific Novel Drug Delivery Systems Market Size Market Share by Type (2017-2028)
• Figure 36. Asia Pacific Novel Drug Delivery Systems Market Size Market Share by Application (2017-2028)
• Figure 37. Asia Pacific Novel Drug Delivery Systems Market Size Share by Region (2017-2028)
• Figure 38. China Novel Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 39. Japan Novel Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 40. South Korea Novel Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 41. Southeast Asia Novel Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 42. India Novel Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 43. Australia Novel Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 44. Latin America Novel Drug Delivery Systems Market Size YoY (2017-2028) & (US$ Million)
• Figure 45. Latin America Novel Drug Delivery Systems Market Size Market Share by Type (2017-2028)
• Figure 46. Latin America Novel Drug Delivery Systems Market Size Market Share by Application (2017-2028)
• Figure 47. Latin America Novel Drug Delivery Systems Market Size Share by Country (2017-2028)
• Figure 48. Mexico Novel Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 49. Brazil Novel Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 50. Middle East & Africa Novel Drug Delivery Systems Market Size YoY (2017-2028) & (US$ Million)
• Figure 51. Middle East and Africa Novel Drug Delivery Systems Market Size Market Share by Type (2017-2028)
• Figure 52. Middle East and Africa Novel Drug Delivery Systems Market Size Market Share by Application (2017-2028)
• Figure 53. Middle East and Africa Novel Drug Delivery Systems Market Size Share by Country (2017-2028)
• Figure 54. Turkey Novel Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 55. Saudi Arabia Novel Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 56. UAE Novel Drug Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 57. Amgen Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
• Figure 58. Teva Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
• Figure 59. Roche Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
• Figure 60. UCB (Union Chimique Belge) Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
• Figure 61. Celgene Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
• Figure 62. Merck Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
• Figure 63. Gilead Sciences Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
• Figure 64. Sanofi Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
• Figure 65. Pfizer Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
• Figure 66. Takeda Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
• Figure 67. Bausch&Lomb Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
• Figure 68. Samyang Biopharmaceuticals Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
• Figure 69. Johnson & Johnson Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
• Figure 70. TOLMAR Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
• Figure 71. Astellas Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
• Figure 72. AMAG Pharmaceuticals Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
• Figure 73. AbbVie Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
• Figure 74. Dr Reddy Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
• Figure 75. AstraZeneca Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
• Figure 76. Aspen Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
• Figure 77. Acrotech Biopharma Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
• Figure 78. TWi Pharmaceuticals Revenue Growth Rate in Novel Drug Delivery Systems Business (2017-2022)
• Figure 79. Bottom-up and Top-down Approaches for This Report
• Figure 80. Data Triangulation
• Figure 81. Key Executives Interviewed